Document Detail

37-kDa Laminin Receptor Precursor Mediates GnRH-II-Induced MMP-2 Expression and Invasiveness in Ovarian Cancer Cells.
MedLine Citation:
PMID:  21193558     Owner:  NLM     Status:  In-Data-Review    
GnRH-II enhances ovarian cancer cell invasion in an autocrine manner. We have now found that GnRH-II increases 37-kDa laminin receptor precursor (LRP) production in GnRH receptor (GnRHR)-positive OVCAR-3 and CaOV-3 ovarian cancer cells, while small interfering RNA (siRNA)-mediated depletion of GnRH-II or GnRHR mRNA abrogates this. The invasiveness of ovarian cancer cells is also reduced >85% by siRNA-mediated knockdown of LRP levels and >50% by pretreatment of Matrigel with a synthetic peptide that blocks interactions between laminin and the 67-kDa nonintegrin laminin receptor which comprises two LRP subunits. Conversely, overexpressing LRP in CaOV-3 cells increases their invasiveness 5-fold, while overexpressing LRP with a nonfunctional laminin-binding site does not. Depletion of LRP by siRNA treatment reduces CaOV-3 cell attachment to laminin-coated plates by ∼80% but only reduces their binding to Matrigel by ∼20%. Thus, while LRP influences CaOV-3 cell adhesion to laminin, LRP must act in other ways to enhance invasion. Matrix metalloproteinases (MMPs) are key mediators of invasion, and LRP siRNA treatment of OVCAR-3 and CaOV-3 cells inhibits MMP-2 but not MMP-9 mRNA levels. Overexpressing LRP in these cells increases MMP-2 production specifically, while a laminin-binding deficient LRP does not. Importantly, LRP siRNA treatment abolishes GnRH-II-induced MMP-2 production, and invasion in OVCAR-3 and CaOV-3 cells, which was also seen after MMP-2 siRNA treatment. These results suggest that GnRH-II-induced LRP expression increases the amount of the 67-kDa nonintegrin laminin receptor, which appears to interact with laminin in the extracellular matrix to promote MMP-2 expression and enhance ovarian cancer cell invasion.
Song Ling Poon; Christian Klausen; Geoffrey L Hammond; Peter C K Leung
Related Documents :
1473238 - A possible explanation for the differential cancer incidence in the intestine, based on...
7721948 - In vivo analysis of cadherin function in the mouse intestinal epithelium: essential rol...
7035568 - An enzymatic method for preparation of dissociated murine peyer's patch cells enriched ...
2688578 - Endpolyploidy and digestion in the midgut of rhodnius prolixus stål (hemiptera: reduvi...
24288118 - Probing the intracellular glutathione redox potential by in-cell nmr spectroscopy.
18469948 - Cytological expression of early response to infection by heterodera glycines ichinohe i...
Publication Detail:
Type:  Journal Article     Date:  2010-12-30
Journal Detail:
Title:  Molecular endocrinology (Baltimore, Md.)     Volume:  25     ISSN:  1944-9917     ISO Abbreviation:  Mol. Endocrinol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8801431     Medline TA:  Mol Endocrinol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  327-38     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hnf1? (MODY3) regulates ?-cell-enriched MafA transcription factor expression.
Next Document:  PERK activation at low glucose concentration is mediated by SERCA pump inhibition and confers preemp...